Related references
Note: Only part of the references are listed.Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer
Matthew P. Deek et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Consolidative Radiotherapy in Oligometastatic Lung Cancer: Patient Selection With a Prediction Nomogram
Cole Friedes et al.
CLINICAL LUNG CANCER (2020)
Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure
Dario Pasalic et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer The ORIOLE Phase 2 Randomized Clinical Trial
Ryan Phillips et al.
JAMA ONCOLOGY (2020)
Stereotactic Radiosurgery and Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease
H. Chen et al.
CLINICAL ONCOLOGY (2020)
Isolated progression of metastatic lung cancer: Clinical outcomes associated with definitive radiotherapy
Cole Friedes et al.
CANCER (2020)
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
David A. Palma et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Yolande Lievens et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis
Ian Poon et al.
JAMA NETWORK OPEN (2020)
Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma
Ciro Franzese et al.
JOURNAL OF UROLOGY (2019)
Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer
Yuanyuan Zhang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Multisite stereotactic body radiotherapy for metastatic non-small-cell lung cancer: Delaying the need to start or change systemic therapy?
Tomas Merino Lara et al.
LUNG CANCER (2018)
Radiosensitivity of Colon and Rectal Lung Oligometastasis Treated With Stereotactic Ablative Radiotherapy
Remy Kinj et al.
CLINICAL COLORECTAL CANCER (2017)
Robot-assisted Extracranial Stereotactic Radiotherapy of Adrenal Metastases in Oligometastatic Non-small Cell Lung Cancer
Eren Celik et al.
ANTICANCER RESEARCH (2017)
Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up
Linda Agolli et al.
CLINICAL COLORECTAL CANCER (2017)
A multi-national report on stereotactic body radiotherapy for oligometastases: Patient selection and follow-up*
Roi Dagan et al.
ACTA ONCOLOGICA (2016)
Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT)
Anthony C. Wong et al.
CANCER (2016)
Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases
Mette Marie Fode et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival
T. de Vin et al.
ANNALS OF ONCOLOGY (2014)
An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-Small-Cell Lung Cancer
Allison B. Ashworth et al.
CLINICAL LUNG CANCER (2014)
Potentially curative stereotactic body radiation therapy (SBRT) for single or oligometastasis to the lung
Dongryul Oh et al.
ACTA ONCOLOGICA (2012)
A 10-Year Single-Center Experience on 708 Lung Metastasectomies The Evidence of the International Registry of Lung Metastases
Monica Casiraghi et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Share Paper
